See All Slides - tctmd.com

Slides

Presentation TCT 2012

Background Medical and Device Therapies for Patients with VADs

Presenter: Emma Birks

October 23, 2012

Presentation TCT 2012

CorAssist

Presenter: Mitchell Krucoff

October 23, 2012

Presentation TCT 2012

The Israeli "Start-up Nation" Approach to Medical Innovation: Defining the Ecosystem

Presenter: Ran Kornowski

October 22, 2012

Presentation TCT 2012

Step 2: Invention

Presenter: Richard Stack

October 22, 2012

Presentation TCT 2012

Step 4: Preclinical Assessments

Presenter: Juan Granada

October 22, 2012

Presentation TCT 2012

"Japan First:" Speeding Device Introduction in Japan

Presenter: Akihiro Koide

October 24, 2012

Presentation TCT 2012

Provisional Stenting Technique Cases 3 and 4: Second Stent Needed (Before and After the First Stent)

Presenter: Jeffrey Moses

October 22, 2012

Presentation TCT 2013

Admission At Nights Or Weekends Has No Adverse Effect On Mortality For ST Elevation Myocardial Infarction Patients Treated By Primary Percutaneous Coronary Intervention: Single...

Presenter: Refai Showkathali, John Davies, Paul Kelly, Jeremy Sayer, Rajesh Aggarwal, Gerald Clesham

January 31, 2013

$Association of the P53 codon 72 polymorphism with infarct size and left ventricular ejection fraction in patients with ST-segment elevation acute coronary syndrome$

Presentation TCT 2013

Association of the P53 codon 72 polymorphism with infarct size and left ventricular ejection fraction in patients with ST-segment elevation acute coronary syndrome

Presenter: Juan Rama Merchan, Ignacio Cruz-Gonz?lez, Rogelio Gonzalez Sarmiento, Irene Rodriguez Hernandez, Ana Cordero Vaquero, Ana Martin Garcia, Candido Mart?n Luengo

January 31, 2013

$The impact of sirolimus-eluting stent and evelolimus-eluting stent on the in-stent restenosis and stent fracture; evaluating peri-stent contrast staining lesions after...$

Presentation TCT 2013

The impact of sirolimus-eluting stent and evelolimus-eluting stent on the in-stent restenosis and stent fracture; evaluating peri-stent contrast staining lesions after...

Presenter: Tahei Ichinohe, Kazushige Kadota, Haruki Eguchi, Seiji Habara, Hiroyuki Tanaka, Takeshi Tada, Yasushi Fuku, Naoki Oka, Hiroyuki Yamamoto, Satoki Fujii, Tsuyoshi Goto, Kazuaki Mitsudo

January 31, 2013

Advertisement

Slides

Background Medical and Device Therapies for Patients with VADs

CorAssist

The Israeli "Start-up Nation" Approach to Medical Innovation: Defining the Ecosystem

Step 2: Invention

Step 4: Preclinical Assessments

"Japan First:" Speeding Device Introduction in Japan

Provisional Stenting Technique Cases 3 and 4: Second Stent Needed (Before and After the First Stent)

Admission At Nights Or Weekends Has No Adverse Effect On Mortality For ST Elevation Myocardial Infarction Patients Treated By Primary Percutaneous Coronary Intervention: Single...

Association of the P53 codon 72 polymorphism with infarct size and left ventricular ejection fraction in patients with ST-segment elevation acute coronary syndrome

The impact of sirolimus-eluting stent and evelolimus-eluting stent on the in-stent restenosis and stent fracture; evaluating peri-stent contrast staining lesions after...

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content